Physician

Fadi Eliya, MD

According to 2025 Medicare claims, Fadi Eliya, MD (NPI: 1669686119) practices urology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is MICHIGAN INSTITUTE OF UROLOGY PC (NPI: 1427027416; TIN: 381962231) and primary practice location at 48154-3075.

Eliya's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,171 traditional Medicare patients, billed 13,103 HCPCS/CPT codes, and received $441,411 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,406 prescription claims across 1,261 beneficiaries totaling $2,132,406 in drug costs, led by Xtandi (Enzalutamide). DME data shows 58 claims. Open Payments data shows 150 records totaling $4,928. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $275,054 to $2,132,406. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	812	10,254	$367,660
2016	980	11,715	$466,630
2017	1,078	15,131	$552,167
2018	1,161	13,676	$515,775
2019	1,300	14,342	$492,539
2020	1,165	19,647	$659,095
2021	1,282	19,534	$718,010
2022	1,188	13,637	$636,030
2023	1,044	10,092	$386,246
2024	1,171	13,103	$441,411

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	388	1,485	$275,054
2016	522	2,161	$354,177
2017	658	2,786	$497,226
2018	742	3,351	$418,701
2019	881	3,715	$628,283
2020	924	4,092	$871,124
2021	1,167	4,886	$1,592,514
2022	1,217	5,349	$1,769,793
2023	1,212	5,271	$1,618,665
2024	1,261	5,406	$2,132,406

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	112	$9,212
2016	N/R	155	$13,459
2017	N/R	187	$25,626
2018	N/R	183	$30,969
2019	27	332	$54,171
2020	38	306	$42,079
2021	12	189	$30,389
2022	N/R	84	$18,582
2023	N/R	51	$16,683
2024	11	58	$22,170

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	741	1,298	$93
84153	Psa (prostate specific antigen) measurement, total	332	432	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	645	1,002	$12
51798	Ultrasound measurement of bladder capacity after voiding	306	426	$8
81003	Automated urinalysis test	660	1,105	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	92	2,760	$1,290,931
Myrbetriq	Mirabegron	259	12,962	$189,068
Gemtesa	Vibegron	217	10,676	$166,981
Orgovyx	Relugolix	31	922	$82,211
Xyosted	Testosterone Enanthate	59	1,654	$36,378

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	11	58	$22,170

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	150	$4,928	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Fadi Eliya, MD?

Tedicare shows public-source Medicare data for Fadi Eliya, MD (NPI 1669686119), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Fadi Eliya, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Fadi Eliya, MD?

Fadi Eliya, MD is linked to MICHIGAN INSTITUTE OF UROLOGY PC (billing NPI 1427027416) in the available physician profile data.

Does Fadi Eliya, MD have Open Payments data?

Fadi Eliya, MD has 150 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.